Zimmer Biomet Holdings, Inc. · ZBH · Next earnings

Zimmer Biomet Holdings, Inc. reports Tuesday, Feb 9, 2027

ZBH reports before market open with consensus EPS at $2.50 and revenue at $2.29B. Last quarter: Zimmer Biomet raises 2026 outlook as hip and technology growth offset knee weakness

Reports Before market open96 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.50 Calendar consensus
Consensus revenue $2.29B Calendar consensus
Report date Feb 9, 2027 Tuesday, date estimated
Session Before market open 96 days away

Where ZBH left off: FY2026 Q3

Full report

Zimmer Biomet raises 2026 outlook as hip and technology growth offset knee weakness

EPS surprise — Reported — vs $1.88
Revenue surprise — Reported — vs $2.04B
Stock move +14.6% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised full-year organic constant-currency sales growth guidance to 3–3.5% and adjusted EPS guidance to $8.50–$8.60.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Knee sales-force reorganization may continue to disrupt performance.
  • China market headwinds are expected to weigh on Q4 growth.
  • Pricing pressure and higher manufacturing and SG&A costs may constrain margins.
  • Monogram's regulatory timeline and commercial impact remain uncertain.
  • The sustainability of hip and S.E.T. growth is not yet established.

Questions analysts left open

  • How quickly the knee sales-force transition translates into improved results.
  • The scale and duration of China headwinds.
  • Whether hip and S.E.T. growth rates can be sustained.
  • Monogram's regulatory path, timing and market impact.
  • The scope and valuation discipline of future M&A.

Ask FN2 about ZBH next report

Transcript, numbers and history already loaded
What should I watch for in ZBH's next earnings report?How did ZBH guide last quarter, and is consensus above or below that?Give me the bull and bear case going into ZBH earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the ZBH recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent ZBH quarters

All ZBH earnings
+14.6%FY2026 Q3+2.5%FY2026 Q2-10.6%FY2026 Q1+1.9%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.